Biotech · Private company · Ellicott City, MD, US
Natsar Pharmaceuticals, Inc.
Track this companyFree. Adds Natsar Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Drug development of RK-33 for breast cancer treatmentFiscal year 2026 · $615.2KNIH RePORTER 5R44CA295155-02 · fetched Nov 12, 2026
- Drug development of RK-33 for breast cancer treatmentFiscal year 2025 · $1.6MNIH RePORTER 1R44CA295155-01A1 · fetched Nov 12, 2026